MRC Technology

LifeArc, AUTM partner on training for scholars in technology transfer

Wednesday, August 30, 2017

LifeArc, the medical research charity formerly known as MRC Technology, has partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide essential training for scientists seeking a career in life sciences technology transfer. This joint initiative emphasizes the commitment of both organizations to improve access to the technology transfer profession.

[Read More]

LifeArc, previously MRC Technology, to invest £500M

Thursday, June 15, 2017

LifeArc, the U.K. medical research charity previously known as MRC Technology, announced plans to improve the lives of patients suffering from diseases that present the greatest challenges to medical research. By investing up to £500 million over the next five years, LifeArc will seek to generate, fund and champion innovations in antimicrobials, neuroscience, personalized oncology and respiratory medicine.

[Read More]

Dementia Consortium funds dementia treatments team

Wednesday, March 15, 2017

The Dementia Consortium, a public-private partnership initiative bridging the gap between academic research and the pharmaceutical industry, is supporting a project led by Dr. David Brough at the University of Manchester to develop novel therapeutics for Alzheimer’s disease targeting the immune system. This is the fifth project supported by the Dementia Consortium, and has been awarded £191,757 by the initiative.

[Read More]

MRC Technology licenses antibody to Newsummit Biopharma for hepatitis C

Tuesday, March 14, 2017

MRC Technology, a medical research charity, has licensed an antibody to Newsummit Biopharma, a China-based drug development process solutions provider, for development of a novel therapeutic for treatment of Hepatitis C virus (HCV) infection. The antibody was humanized by MRC Technology scientists, and originated in the laboratory of Prof. Arvind Patel, of the MRC-University of Glasgow Centre for Virus Research (CVR).

[Read More]

MRC Technology Centre relocates to expand diagnostics research capability

Tuesday, January 17, 2017

MRC Technology, an independent medical research charity, has announced the relocation of its Centre for Diagnostics Development (CDD) to Nine, Edinburgh BioQuarter, in the U.K. The move forms part of the charity’s investment of over £7 million over the next five years to further its work accelerating diagnostic research into the clinic. CDD will potentially double its headcount over the same period.

[Read More]